Literature DB >> 16632825

Naloxone does not increase the minimum alveolar anesthetic concentration of sevoflurane in mice.

Mark Liao1, Michael J Laster, Edmond I Eger, Michael Tang, James M Sonner.   

Abstract

Several previous studies concluded that opioid receptors do not mediate the capacity of inhaled anesthetics to produce immobility in the face of noxious stimulation because administration of naloxone (a nonspecific opioid receptor antagonist) does not increase the minimum alveolar anesthetic concentration (MAC) of inhaled anesthetic that produces immobility in 50% of subjects given a noxious stimulation. In contrast, a recent study found that 0.1 mg/kg naloxone given intraperitoneally increased sevoflurane MAC in mice by 18% (P < 0.01). We repeated the recent study with sevoflurane in the same strain of mice, administering nothing (control), 0.1 mg/kg, and 1.0 mg/kg of naloxone. Our study differed in that we also tested a parallel group given saline rather than naloxone. We were blinded to drug administration. MAC decreased 4.8% +/- 11.0% (mean+/- sd) and 2.4% +/- 12.5% with the first and second administrations of saline. Similarly, MAC decreased 4.7% +/- 7.1% and 5.5% +/- 10.0% with the administration of 0.1 mg/kg and 1.0 mg/kg of naloxone. We do not find that naloxone increases MAC. Opioid receptors do not underlie a portion of the capacity of inhaled anesthetics to produce immobility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632825     DOI: 10.1213/01.ane.0000204254.87933.f6

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

1.  Combining sevoflurane anesthesia with fentanyl-midazolam or s-ketamine in laboratory mice.

Authors:  Nikola Cesarovic; Paulin Jirkof; Andreas Rettich; Flora Nicholls; Margarete Arras
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

2.  Inner ear insult ablates the arousal response to hypoxia and hypercarbia.

Authors:  T Allen; A J Garcia Iii; J Tang; J M Ramirez; D D Rubens
Journal:  Neuroscience       Date:  2013-09-08       Impact factor: 3.590

3.  GABA(A) receptor antagonism increases NMDA receptor inhibition by isoflurane at a minimum alveolar concentration.

Authors:  Robert J Brosnan
Journal:  Vet Anaesth Analg       Date:  2011-05       Impact factor: 1.648

Review 4.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

5.  Naltrexone does not affect isoflurane minimum alveolar concentration in cats.

Authors:  Robert J Brosnan; Bruno H Pypendop; Chalon R Majewski-Tiedeken; Yael Shilo-Benjamini; Jan E Ilkiw
Journal:  Vet Anaesth Analg       Date:  2012-12-24       Impact factor: 1.648

6.  Rat dorsal horn nociceptive-specific neurons are more sensitive than wide dynamic range neurons to depression by immobilizing doses of volatile anesthetics: an effect partially reversed by the opioid receptor antagonist naloxone.

Authors:  Linda S Barter; Earl E Carstens; Steven L Jinks; Joseph F Antognini
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

Review 7.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility?

Authors:  Edmond I Eger; Douglas E Raines; Steven L Shafer; Hugh C Hemmings; James M Sonner
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

8.  Increased NMDA receptor inhibition at an increased Sevoflurane MAC.

Authors:  Robert J Brosnan; Roberto Thiesen
Journal:  BMC Anesthesiol       Date:  2012-06-06       Impact factor: 2.217

9.  Inhibition of firefly luciferase by general anesthetics: effect on in vitro and in vivo bioluminescence imaging.

Authors:  Marleen Keyaerts; Isabel Remory; Vicky Caveliers; Karine Breckpot; Tomas J Bos; Jan Poelaert; Axel Bossuyt; Tony Lahoutte
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

10.  Remote and Anesthetic-Induced Myocardial Preconditioning Is Preserved in Atherosclerotic LDL Receptor-/- Mice In Vivo.

Authors:  Walter Petermichl; Kathrin Eglmeier; Henriette Hesse; Michael Gruber; Bernhard Graf; Andre Bredthauer; Andreas Redel
Journal:  Cardiovasc Ther       Date:  2021-05-24       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.